Cargando…
Exploring the efficacy of using hypertonic saline for nebulizing treatment in children with bronchiolitis: a meta-analysis of randomized controlled trials
BACKGROUND: Inhaled hypertonic saline (HS) has shown benefit in decreasing airway edema in acute bronchiolitis which is the most common lower respiratory infection resulting in dyspnea among infants under 2 years old. The aim of this systematic review and meta-analysis was to evaluate the efficacy a...
Autores principales: | Hsieh, Chia-Wen, Chen, Chiehfeng, Su, Hui-Chuan, Chen, Kee-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489028/ https://www.ncbi.nlm.nih.gov/pubmed/32928154 http://dx.doi.org/10.1186/s12887-020-02314-3 |
Ejemplares similares
-
Epinephrine Improves the Efficacy of Nebulized Hypertonic Saline in Moderate Bronchiolitis: A Randomised Clinical Trial
por: Flores-González, J. Carlos, et al.
Publicado: (2015) -
3% nebulized hypertonic saline versus normal saline for infants with acute bronchiolitis: A systematic review and meta-analysis of randomized controlled trials
por: Yu, Jin-Feng, et al.
Publicado: (2022) -
Effects of nebulized epinephrine in association with hypertonic saline for infants with acute bronchiolitis: A systematic review and meta‐analysis
por: Pereira, Renan A., et al.
Publicado: (2022) -
Effectiveness of 3% hypertonic saline nebulization in acute bronchiolitis among Indian children: A quasi-experimental study
por: Gupta, Harsh V., et al.
Publicado: (2016) -
Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial
por: Beal, Gaëlle, et al.
Publicado: (2019)